Quick Order Cart

Cat. No. ARG1172

CLMP Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The CLMP Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population derived from the Raji B lymphoblastoid cell line, carrying targeted disruption of the CLMP gene, which encodes a tight junction-associated homophilic adhesion molecule. This model enables investigation of CLMP??s role in mediating cell-cell contacts through scaffolding with ZO-1 and occludin and regulating paracellular barrier integrity. Ideal for studying B-cell adhesion, tight junction dynamics, and intestinal barrier dysfunction linked to obesity and inflammatory bowel disease. Suitable for Western blotting, immunofluorescence, co-immunoprecipitation, and cell aggregation assays, it serves as a versatile tool for molecular and cellular biology research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    CLMP

    Gene Identifier

    NCBI Gene ID 79827

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CLMP Knockout Raji Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal knockout population of the Raji B lymphoblastoid cell line, harboring targeted disruption of the CLMP (CXADR-like membrane protein) gene. This engineered cell pool offers a loss-of-function model system for dissecting CLMP??s contributions to homophilic cell adhesion, tight junction assembly, and regulation of paracellular permeability. As a polyclonal population, it encompasses a spectrum of editing events, minimizing clonal bias and enhancing the statistical power of downstream functional comparisons to wild-type Raji controls.

The Raji host cell line is an Epstein-Barr virus (EBV)-positive B lymphocyte model derived from a Burkitt lymphoma patient. These suspension-adapted lymphoblastoid cells exhibit key B-cell functions, including antibody production and antigen presentation, and provide a relevant background for studying adhesion-mediated signaling in hematopoietic cells. Raji cells endogenously express components of epithelial junction complexes under certain conditions, making them suitable for interrogating CLMP??s role in lymphocyte adhesion and barrier-related dynamics.

CLMP localizes to tight junctions and engages in homophilic interactions that scaffold with the zonula occludens protein ZO-1 and the transmembrane protein occludin, linking to the cortical actin cytoskeleton via claudins. This molecular architecture is critical for maintaining epithelial barrier integrity. CLMP expression is regulated by pro-inflammatory cytokines TNF-alpha and TGF-beta, and downstream it modulates the localization and stability of ZO-1, occludin, and claudin-1. In the knockout model, disruption of CLMP is expected to perturb these interactions, leading to compromised junctional complex formation and increased paracellular permeability, paralleling observations in intestinal barrier dysfunction.

In the Raji background, CLMP loss-of-function may reveal novel aspects of B-cell adhesion and activation, given the emerging role of tight junction proteins in lymphocyte homing and immune synapse formation. The polyclonal knockout cells facilitate the study of homophilic adhesion outside traditional epithelial contexts, enabling researchers to explore how CLMP-dependent cell-cell contacts influence B-cell behavior, including aggregation, signaling, and crosstalk with other immune cells. This model also aids in modeling diseases associated with barrier breakdown, such as inflammatory bowel disease and obesity, where CLMP has been implicated.

Researchers can employ these polyclonal knockout cells in a range of assays: Western blotting and RT-qPCR for expression analysis, immunofluorescence and flow cytometry for protein localization and surface expression, co-immunoprecipitation for protein-protein interactions with ZO-1 or occludin, and cell aggregation assays to quantify adhesion. Transcriptomic profiling via RNA-seq further enables discovery of downstream pathways altered by CLMP loss. This product is an indispensable resource for advancing tight junction biology, lymphocyte adhesion mechanisms, and barrier function studies. For inquiries, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)